ORKA
Oruka Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Oruka Therapeutics (ORKA) Stock: Buy, Sell, or Hold?
$105.73
-1.44 (-1.34%)
▼
5d:
+10.11%
30d:
+37.88%
90d:
-4.78%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 11, 2026
0d
Protect ORKA Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
36/100
Position
EXTENDED
30-Day Fair Range
$76.85 – $98.06
Position: EXTENDED
Forward P/E & Valuation
-36.4x
Next 12M consensus est.
Wall Street Target
$156.17
+45.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$94.05 / $113.24
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ORKA shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ORKA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ORKA is currently trading at $105.73, which is considered extended relative to its 30-day fair value range of $76.85 to $98.06.
Technical Outlook: Technically, ORKA is showing sideways momentum. Immediate support is located at $94.05, while resistance sits at $113.24.
Market Sentiment: ORKA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $156.17 (+45.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ORKA is showing sideways momentum. Immediate support is located at $94.05, while resistance sits at $113.24.
Market Sentiment: ORKA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $156.17 (+45.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$76.85 -
$98.06
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$76.85 -
$98.06
Current vs Trading Range
EXTENDED
Support Level
$94.05
Resistance Level
$113.24
Current Trend
Sideways
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding ORKA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range (+7.8% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 45.7% below Wall St target ($156.17)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-36.40
Wall Street Target
$156.17
(+45.7%)
Share ORKA Analysis
Share this live ORKA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ORKA)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 27, 2026
Daily AI digest
AI Retail Discussion Summary:
Oruka Therapeutics reported positive Phase 2b trial results for ORKA-001 in psoriasis, with 61% of patients achieving complete skin clearance and a safety profile comparable to placebo.
Key Retail Themes:
Positive clinical trial results for ORKA-001
Infrequent dosing vision for chronic disease treatment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:43 PM ET
Data refreshes hourly during market hours. Next update: 2:43 PM
Data refreshes hourly during market hours. Next update: 2:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ORKA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 32 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 32 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 24 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 48 HOLD |
Advanced ORKA Option Strategies
Professional options setups generated by AI based on today's ORKA price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ORKA Research Pages
